Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
71.36
+1.67 (2.40%)
Oct 27, 2025, 4:00 PM EDT - Market closed
Claritev Market Cap
Claritev has a market cap or net worth of $1.18 billion as of October 28, 2025. Its market cap has increased by 606.37% in one year.
Market Cap
1.18B
Enterprise Value
5.78B
1-Year Change
606.37%
Ranking
Category
Stock Price
$71.36
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $1.18B, an increase of 383.80%. That is a compound annual growth rate of 32.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 1.18B | 391.88% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |